KB407 (Nebulization)
KB407-02
Phase 1 mab active
Quick answer
KB407 (Nebulization) for Cystic Fibrosis is a Phase 1 program (mab) at Krystal Biotech with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Krystal Biotech
- Indication
- Cystic Fibrosis
- Phase
- Phase 1
- Modality
- mab
- Status
- active